Trial Profile
Treatment of Forehead/Glabellar Rhytide Complex With Onabotulinum Toxin A Versus Incobotulinum Toxin A Injection: A Split-face, Double-blinded, Randomized Control Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Mar 2024
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Skin wrinkles
- Focus Therapeutic Use
- 14 Mar 2024 Planned End Date changed from 1 Dec 2023 to 1 Dec 2024.
- 14 Mar 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Dec 2024.
- 17 Feb 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.